Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000038.pdf 0001708138-22-000038.xls
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000039.pdf 0001708138-22-000039.xls
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001708138-22-000040.pdf 0001708138-22-000040.xls
Apr 11, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000040.pdf 0001883850-22-000040.xls
Apr 19, 2022	SC TO-C	Written public communication relating to an issuer or third party tender offer	View HTML 0001104659-22-047376.pdf 0001104659-22-047376.xls
Apr 21, 2022	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML 0000930413-22-000787.pdf 0000930413-22-000787.xls
Apr 21, 2022	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000930413-22-000789.pdf 0000930413-22-000789.xls
Apr 21, 2022	DEFA14A	Additional proxy soliciting materials - definitive	View HTML 0000930413-22-000790.pdf 0000930413-22-000790.xls
May 02, 2022	SC TO-T	Tender offer schedule and amendment filed by a third party.	View HTML 0001104659-22-054147.pdf 0001104659-22-054147.xls
May 03, 2022	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-22-000043.pdf 0001883850-22-000043.xls

Data provided by Kaleidoscope.

Investors & Media